Foeldvari, Ivan <br/><br/>
Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.  [electronic resource] 

 -  The Journal of rheumatology  May 2007 
 - 1146-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0315-162X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adolescent<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Arthritis, Juvenile--complications<br/>Child<br/>Cohort Studies<br/>Cross-Sectional Studies<br/>Drug Resistance<br/>Etanercept<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Infliximab<br/>International Cooperation<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Uveitis--drug therapy